Scarica l'app Stockscreener
30.99
1.11%
0.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRNX Giù?
Forum
Previsione
Precedente Chiudi:
$30.65
Aprire:
$30.67
Volume 24 ore:
1.14M
Relative Volume:
1.37
Capitalizzazione di mercato:
$2.92B
Reddito:
$4.72M
Utile/perdita netta:
$-277.91M
Rapporto P/E:
-8.3083
EPS:
-3.73
Flusso di cassa netto:
$-203.56M
1 W Prestazione:
+0.23%
1M Prestazione:
+5.88%
6M Prestazione:
-6.68%
1 anno Prestazione:
-41.20%
Intervallo 1D:
$30.25
$31.22
Intervallo di 1 settimana:
$29.91
$31.45
Portata 52W:
$24.10
$62.53
Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile
Nome
Crinetics Pharmaceuticals Inc
Settore
Industria
Telefono
858-450-6464
Indirizzo
6055 LUSK BLVD., SAN DIEGO, CA
Confronta CRNX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRNX
Crinetics Pharmaceuticals Inc
|
30.99 | 2.89B | 4.72M | -277.91M | -203.56M | -3.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | Goldman | Neutral |
| 2025-03-25 | Iniziato | Stifel | Buy |
| 2025-02-11 | Iniziato | TD Cowen | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Peer Perform |
| 2025-01-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-06 | Iniziato | Citigroup | Buy |
| 2024-01-16 | Iniziato | Morgan Stanley | Overweight |
| 2023-12-21 | Iniziato | Jefferies | Hold |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-08-31 | Iniziato | Oppenheimer | Outperform |
| 2023-04-24 | Iniziato | Piper Sandler | Overweight |
| 2023-03-30 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-30 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-11-23 | Iniziato | Evercore ISI | Outperform |
| 2021-06-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-12-23 | Iniziato | ROTH Capital | Buy |
| 2019-02-14 | Iniziato | H.C. Wainwright | Buy |
| 2018-08-13 | Iniziato | JP Morgan | Neutral |
| 2018-08-13 | Iniziato | Leerink Partners | Outperform |
| 2018-08-13 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Crinetics Pharmaceuticals Inc Borsa (CRNX) Ultime notizie
Crinetics Pharmaceuticals Inc. stock retracement – recovery analysisEarnings Recap Report & Low Risk Entry Point Tips - Newser
How to build a custom watchlist for Crinetics Pharmaceuticals Inc.July 2025 Snapshot & Target Return Focused Picks - Newser
Published on: 2025-08-30 23:56:26 - Newser
What’s the recovery path for long term holders of Crinetics Pharmaceuticals Inc.Quarterly Trade Summary & AI Powered Market Entry Ideas - Newser
Can Crinetics Pharmaceuticals Inc. Outperform Peers After Recent Pullback getLinesFromResByArray error: size == 0 - thegnnews.com
Published on: 2025-08-30 21:02:46 - Newser
Statistical indicators supporting Crinetics Pharmaceuticals Inc.’s strengthProfit Target & Intraday High Probability Setup Alerts - Newser
Is Crinetics Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Spike Watch & Accurate Buy Signal Alerts - Newser
Should you wait for a breakout in Crinetics Pharmaceuticals Inc.Share Buyback & Verified Trade Idea Suggestions - Newser
Crinetics Pharmaceuticals Inc. stock trend forecastFed Meeting & Reliable Price Breakout Signals - Newser
Will Crinetics Pharmaceuticals Inc. stock recover after recent drop2025 Price Targets & Low Risk Entry Point Tips - Newser
Crinetics Pharmaceuticals Inc. stock volume spike explainedRecession Risk & Weekly High Return Forecasts - Newser
Is Crinetics Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - Newser
How to forecast Crinetics Pharmaceuticals Inc. trends using time seriesJuly 2025 Price Swings & Expert Verified Movement Alerts - Newser
Understanding Crinetics Pharmaceuticals Inc.’s price movementEarnings Trend Report & Weekly Stock Breakout Alerts - Newser
Published on: 2025-08-30 03:59:25 - Newser
Using Ichimoku Cloud for Crinetics Pharmaceuticals Inc. technicalsJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Heatmap analysis for Crinetics Pharmaceuticals Inc. and competitorsEarnings Risk Summary & Low Drawdown Trading Strategies - Newser
Analyzing Crinetics Pharmaceuticals Inc. with risk reward ratio chartsQuarterly Profit Review & Capital Efficiency Focused Strategies - Newser
Building trade automation scripts for Crinetics Pharmaceuticals Inc.Market Performance Report & Verified Short-Term Plans - Newser
How to interpret RSI for Crinetics Pharmaceuticals Inc. stock2025 Technical Patterns & Safe Capital Growth Trade Ideas - Newser
What momentum shifts mean for Crinetics Pharmaceuticals Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Risk Analysis: Will Crinetics Pharmaceuticals Inc. stock go up in YEARTrade Exit Summary & Weekly High Conviction Trade Ideas - sundaytimes.kr
Volume spikes in Crinetics Pharmaceuticals Inc. stock – what they mean2025 Market Overview & Growth Focused Investment Plans - Newser
Combining price and volume data for Crinetics Pharmaceuticals Inc.2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Using data models to predict Crinetics Pharmaceuticals Inc. stock movementPortfolio Performance Summary & Safe Entry Trade Signal Reports - Newser
What high frequency data says about Crinetics Pharmaceuticals Inc.Market Movers & Daily Volume Surge Trade Alerts - Newser
Published on: 2025-08-29 14:28:07 - Newser
What is the cash position of Crinetics Pharmaceuticals Inc.2025 Key Highlights & Free Daily Entry Point Trade Alerts - sundaytimes.kr
Crinetics Pharmaceuticals Inc Azioni (CRNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Crinetics Pharmaceuticals Inc Azioni (CRNX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Pizzuti Dana | Chief Med and Dev Officer |
Aug 22 '25 |
Sale |
30.43 |
30,000 |
912,900 |
66,270 |
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):